Stock BELLEROPHON THERAPEUTICS LLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Bellerophon Therapeutics LLC Nasdaq

Equities

End-of-day quote Nasdaq
Other stock markets
- - Intraday chart for Bellerophon Therapeutics LLC
02/05 North American Morning Briefing : Stock Futures -2- DJ
25/04 North American Morning Briefing : More Tech -2- DJ

Chart calendar Bellerophon Therapeutics LLC

8ec63cec0c88609434998fdb92.uaU54b3zWN3133zmrOIY4vJ-phrq4-x6-sjNI8ICFzU.ysRqrfqZHZ6W6U6rybMsoKUf11CojLYVr4aAc7Z6R2L36VWp_MYC776UHw~7c708b458222e388726b04ed803e656c

Upcoming events on Bellerophon Therapeutics LLC

No events available

Past events on Bellerophon Therapeutics LLC

01/03/2024 09:30 pm Extraordinary Shareholders Meeting - Restructuring Vote
07/06/2023 Annual General Meeting
05/06/2023 06:00 pm INOpulse Phase 3 Clinical Trial Results Call
16/05/2023 02:20 am Q1 2023 Earnings Release
31/03/2023 06:00 pm Q4 2022 Earnings Release
14/11/2022 07:00 pm Q3 2022 Earnings Release
15/08/2022 06:00 pm Interim 2022 Earnings Release
01/06/2022 07:30 pm Annual General Meeting
18/05/2022 02:45 am American Thoracic Society International Conference
11/05/2022 06:00 pm Q1 2022 Earnings Release
01/04/2022 01:31 am FY 2021 Earnings Release
10/01/2022 05:30 pm H.C. Wainwright BioConnect Conference
05/01/2022 LifeSci Partners Corporate Access Event
15/11/2021 07:00 pm Q3 2021 Earnings Release
13/09/2021 05:30 pm H.C. Wainwright Global Investment Conference
05/08/2021 06:00 pm Interim 2021 Earnings Release
04/06/2021 12:30 am Jefferies Healthcare Conference
26/05/2021 Annual General Meeting
11/05/2021 06:00 pm Q1 2021 Earnings Release
11/03/2021 07:00 pm FY 2020 Earnings Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		-27,9
-31,6
11.75%		-17,5
-18,1
3.55%		-26,3
-26,8
1.92%		-20,2
-21,4
5.57%		-22,4
-22,4
0.05%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-2,63
-10,0
73.78%		-15,1
-15,9
5.24%		-26,9
-27,4
2.12%		-19,6
-20,7
5.71%		-22,2
-22,3
0.05%
Net income
Million USD		Released
Forecast
Spread 		2,81
-4,57
161.52%		-13,3
-14,1
5.92%		-24,7
-26,0
4.95%		-17,8
-18,9
6.25%		-19,8
-19,9
0.35%
EPS
USD		Released
Forecast
Spread 		0,65
-1,20
154.08%		-2,95
-3,00
1.67%		-3,17
-3,34
5.09%		-1,87
-1,94
3.61%		-2,08
-2,03
-2.72%
Announcement Date14/03/1906/04/2011/03/2131/03/2231/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		5,64
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		-4,80
-6,32
23.94%		-4,27
-5,46
21.74%		-5,64
-5,25
-7.57%		-6,54
-5,79
-12.97%		-5,12
-6,25
18.08%		-5,09
-5,15
1.17%		1,48
-5,78
125.57%		-5,26
-4,40
-19.6%		-2,17
-4,60
52.83%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,63
-6,32
26.62%		-4,27
-5,46
21.76%		-5,64
-5,25
-7.55%		-6,52
-5,79
-12.74%		-5,07
-6,25
18.83%		-5,02
-5,15
2.51%		1,55
-5,75
126.85%		-5,14
-4,34
-18.47%		-1,92
-4,58
58.03%
Net income
Million USD		Released
Forecast
Spread 		-4,63
-6,32
26.62%		-4,27
-5,46
21.76%		-5,64
-5,25
-7.55%		-4,11
-5,79
29.04%		-5,07
-6,25
18.83%		-5,02
-5,15
2.51%		2,82
-5,19
154.4%		-5,14
-4,34
-18.47%		-1,92
-4,58
58.03%
EPS
USD		Released
Forecast
Spread 		-0,49
-0,63
22.22%		-0,45
-0,52
13.46%		-0,59
-0,55
-8.26%		-0,43
-0,61
28.93%		-0,53
-0,59
9.4%		-0,53
-0,48
-10.42%		0,27
-0,49
155.1%		-0,42
-0,42
0%		-0,16
-0,44
63.64%
Announcement Date15/11/2131/03/2211/05/2215/08/2214/11/2231/03/2315/05/2314/08/2314/11/23

Upcoming sector events for Bellerophon Therapeutics LLC

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Bellerophon Therapeutics LLC

05/06/2024 01:21 pm PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. BLPH Stock
  4. Stock
  5. Calendar Bellerophon Therapeutics LLC